MIST icon

Milestone Pharmaceuticals
MIST

Overview Fund Activity

24 hedge funds and large institutions have $36.9M invested in Milestone Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.

Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$2.26M
2
KPF
2
K2 Principal Fund
Ontario, Canada
$642K
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$2.42M
4
BFM
4
Boothbay Fund Management
New York
$181K
5
SFI
5
Susquehanna Fundamental Investments
Pennsylvania
$151K

Top Sellers

1
GTC
1
Ghost Tree Capital
New York
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
SFM
3
Sphera Funds Management
Israel
$0
4
PM
4
Prosight Management
Texas
$0
5
BlackRock
5
BlackRock
New York
$18K
Name Market Value Shares Shares
Change 		Shares
Change %
SFM
26
Sphera Funds Management
Israel
– – -67,992 Closed
PM
27
Prosight Management
Texas
– – -41,592 Closed
Renaissance Technologies
28
Renaissance Technologies
New York
– – -10,242 Closed
WAP
29
Wealthcare Advisory Partners
Pennsylvania
– – -52 Closed
CFA
30
Carroll Financial Associates
North Carolina
$0 40 +40 New
1
2